Detailed Information on Publication Record
2006
Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand
RAMOS-LIMA, Francisco J., Oldřich VRÁNA, Adoración G. QUIROGA, Carmen NAVARRO-RANNINGER, Anna HALÁMIKOVÁ et. al.Basic information
Original name
Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand
Name in Czech
Strukturní charakterizace, interakce s DNA, a cytotoxicita nových transplatinových analogů obsahujících jeden alifatický a jeden heterocyklický amino ligand
Authors
RAMOS-LIMA, Francisco J. (724 Spain), Oldřich VRÁNA (203 Czech Republic), Adoración G. QUIROGA (724 Spain), Carmen NAVARRO-RANNINGER (724 Spain), Anna HALÁMIKOVÁ (703 Slovakia), Hana RYBNÍČKOVÁ (203 Czech Republic), Lenka HEJMALOVÁ (203 Czech Republic) and Viktor BRABEC (203 Czech Republic, guarantor)
Edition
Journal of Medicinal Chemistry, USA, American Chemical Society, 2006, 0022-2623
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10610 Biophysics
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 5.115
Organization unit
Faculty of Science
UT WoS
000236979100029
Keywords (in Czech)
transplatina; protinádorový; DNA
Keywords in English
transplatin; antitumor; DNA
Tags
Tags
International impact, Reviewed
Změněno: 22/6/2009 14:15, Mgr. Lenka Hejmalová
V originále
We report in the present work new analogues of clinically ineffective transplatin in which one ammine group was replaced by aliphatic and the other by a planar heterocyclic ligand, namely trans-[PtCl(2)(isopropylamine)(3-(hydroxymethyl)-pyridine)], 1, and trans-[PtCl(2)(isopropylamine)(4-(hydroxymethyl)-pyridine)], 2. The new compounds, in comparison with parent transplatin, exhibit radically enhanced activity in tumor cell lines both sensitive and in particular resistant to cisplatin. Concomitantly, the DNA binding mode of 1 and 2 compared to parent transplatin and other antitumor analogues of transplatin in which only one ammine group was replaced is also different. The results also suggest that the reactions of glutathione and metallothionein-2 with compounds 1 and 2 do not play a crucial role in their overall biological effects. In addition, the monofunctional adducts of 1 and 2 are quenched by glutathione considerably less than the adducts of transplatin, which may potentiate cytotoxic effects of these new platinum complexes.
In Czech
Tato práce popisuje nové analogy klinicky neúčinné tranplatiny, kde je nahrazena jedna aminoskupina alifatickým řetězcem a druhá aminoskupina je nahrazena planárním heterocyklickým ligantem,a to trans-[PtCl(2)(isopropylamine)(3-(hydroxymethyl)-pyridine)], 1, and trans-[PtCl(2)(isopropylamine)(4-(hydroxymethyl)-pyridine)], 2.